Gala J L, Noël H, Rodhain J, Ma D F, Ferrant A
Department of Haematology, St Luc Hospital, Catholic University of Louvain, Brussels, Belgium.
J Clin Pathol. 1995 Jul;48(7):679-81. doi: 10.1136/jcp.48.7.679.
A case of invasive drug resistant thymoma, expressing P-glycoprotein, which showed noticeable clinical response to chemotherapy and the multidrug resistance modulating agents cyclosporin and quinine is reported. A 46 year old man presented with severe left shoulder pain and a diagnosis of invasive lymphoepithelial thymoma was made following chest x ray and a computed tomography scan. The patient underwent extensive chemotherapy without resolution of the tumour. More than 90% of the malignant epithelial cells were strongly positive for P-glycoprotein and based on this observation, cyclosporin and quinine were added to the chemotherapy regimen. The mediastinal mass completely resolved and the size of the pleural metastasis decreased substantially. The patient, however, died of an intercurrent infection. This case report highlights the feasibility and efficacy of using cyclosporin and quinine in combination with VAD chemotherapy in the treatment of invasive thymoma.
报告了一例侵袭性耐药胸腺瘤病例,该肿瘤表达P-糖蛋白,对化疗以及多药耐药调节剂环孢素和奎宁表现出显著临床反应。一名46岁男性因严重左肩疼痛就诊,胸部X线和计算机断层扫描后诊断为侵袭性淋巴上皮胸腺瘤。患者接受了广泛化疗,但肿瘤未消退。超过90%的恶性上皮细胞P-糖蛋白呈强阳性,基于这一观察结果,在化疗方案中加入了环孢素和奎宁。纵隔肿块完全消退,胸膜转移灶大小显著减小。然而,患者死于并发感染。本病例报告强调了环孢素和奎宁联合VAD化疗治疗侵袭性胸腺瘤的可行性和有效性。